Qiagen

Qiagen

Yahoo Finance • 10 days ago

Biomarkers Market Forecasts Growth from $67.95B (2026) to $112.10B by 2031, Profiling Roche, Abbott, Thermo Fisher & Qiagen

Company Logo The global biomarkers market is projected to grow from USD 67.95 billion in 2026 to USD 112.10 billion by 2031, registering a 10.5% CAGR. Growth is driven by precision medicine, companion diagnostics, AI, bioinformatics, digi... Full story

Yahoo Finance • 12 days ago

Qiagen (QGEN), What Is Behind The Fresh Attention Now?

Qiagen (NYSE:QGEN) just received U.S. FDA clearance for its QIAstat-Dx gram-negative bloodstream infection panel, giving American laboratories full access to the company's rapid sepsis testing portfolio in a single automated system. Qiage... Full story

Yahoo Finance • 12 days ago

What Qiagen (QGEN)'s Expanded Sepsis Testing Portfolio Means For Shareholders

Earlier this week, QIAGEN announced that U.S. labs now have access to its full QIAstat-Dx bloodstream infection portfolio after FDA clearance of a one-hour gram-negative bacteria and antibiotic resistance panel, complementing an existing g... Full story

Yahoo Finance • 13 days ago

Magnetic Beads - Global Strategic Business Report: Capitalize on the Surge from $3.3 Billion in 2025 to $7.4 Billion by 2032 as Thermo Fisher Scientific, Merck KGaA, QIAGEN, Bio-Rad Laboratories and Miltenyi Biotec Battle for Leadership

Company Logo Demand is rising in diagnostics, precision medicine and biopharma research, while nanotechnology, automation and AI unlock targeted therapies and high-throughput workflows. Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Magneti... Full story

Yahoo Finance • 13 days ago

QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel

Bloodstream infections can trigger sepsis, a life-threatening response to infection; about 1.7 million U.S. adults develop sepsis each year, contributing to at least 350,000 deaths New QIAstat-Dx test identifies 13 gram-negative bacterial... Full story

Yahoo Finance • last month

Transcriptome Sequencing Market - Global Forecast to 2035; Bulk RNA-Seq Maintains Its Technology Market Lead

Company Logo The global transcriptome sequencing market is projected to reach $11.8 billion by 2035, growing at a 7.3% CAGR from 2025 to 2035. Growth is driven by falling sequencing costs, precision medicine, drug discovery, biomarker dev... Full story

Yahoo Finance • last month

How Qiagen’s New Automation Platform, CEO Transition and Q2 Beat Will Impact Qiagen (QGEN) Investors

In late August 2026, Qiagen launched QIAsymphony Connect, an IVD-compliant automated nucleic acid extraction platform with FDA and EUDAMED listings, while also announcing a CEO transition to Jon Pratt from September 1 and reporting Q2 2026... Full story

Yahoo Finance • last month

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share

Company Logo The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with a 34% share, while Asia Pacific is the fastest-growing region at 15.5%;... Full story

Yahoo Finance • last month

TXG Stock Down Despite Patent Verdict Win Against Parse Biosciences

10x Genomics, Inc. TXG recently secured a favorable jury verdict in its patent infringement case against Parse Biosciences, a Qiagen QGEN subsidiary. The Delaware jury found Parse infringed three patents licensed to Scale Biosciences, uphe... Full story

Yahoo Finance • 2 months ago

QIAGEN Appoints Jonathan M. Pratt as Chief Executive Officer

Jon Pratt brings more than 25 years of leadership experience, most recently as CEO of Filtration Group and previously at Waters, Beckman Coulter Life Sciences and Pall To assume CEO role on September 1, 2026, succeeding Thierry Bernard QIA... Full story

Yahoo Finance • 2 months ago

Will FDA Clearance of QIAstat-Dx Bloodstream Panel Change Qiagen's (QGEN) Syndromic Testing Narrative?

Earlier this week, QIAGEN reported second-quarter 2026 results showing essentially flat year-on-year sales at US$535.04 million but higher net income of US$103.4 million, alongside shareholder-approved changes to its Articles that enable a... Full story

Yahoo Finance • 3 months ago

Key deals this week: MGM, PERF, VRTX, and more

[M A - concept waiting for mergers and acquisitions.3D rendering on yellow background.] fengdr Here's a list of key deals reported across sectors this week: * MGM Resorts (MGM [https://seekingalpha.com/symbol/MGM]) has reportedly start... Full story

Yahoo Finance • 3 months ago

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Thursday afternoon, with the NYSE Healthcare Index shedding 0.5% a PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premiu... Full story

Yahoo Finance • 3 months ago

Stocks making the biggest moves midday: Micron, Paramount Skydance, Mara Holdings, PepsiCo & more

Check out the companies making the biggest moves midday: Micron Technology — The memory chipmaker rose more than 7% after the company said it will invest up to $3 billion to " strengthen the U.S. semiconductor supply-chain ecosystem ." Sha... Full story

Yahoo Finance • 3 months ago

Global Hematologic Malignancies Testing Market Size/Share Worth USD 12.47 Billion by 2035 at a 14.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Hematologic Malignancies Testing Market size & share revenue was valued at approximat... Full story

Yahoo Finance • 4 months ago

IBM upgrade, SpaceX initiation among today's top calls on Wall Street

IBM upgrade, SpaceX initiation among today's top calls on Wall Street The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled... Full story

Yahoo Finance • 4 months ago

Here Are Tuesday’s Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and More

Pre-Market Stock Futures: Futures are trading lower after a mixed start to trading on Monday, following the holiday-shortened week due to the Juneteenth Federal holiday. We may start to see some end-of-the-quarter reallocations and sellin... Full story

Yahoo Finance • 4 months ago

Global Automated Liquid Handling Systems Market Size/Share Worth USD 6.9 Billion by 2035 at a 9.8% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Custom Market Insights [220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Automated Liquid Handling Systems Market size & share revenue was valued at approxima... Full story

Yahoo Finance • 4 months ago

Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now?

Is WVE a good stock to buy? We came across a bullish thesis on Wave Life Sciences Ltd. on Biotech Distilled's Substack. In this article, we will summarize the bulls' thesis on WVE. Wave Life Sciences Ltd.'s share was trading at $5.70 as of... Full story

Yahoo Finance • 4 months ago

Is AbbVie Inc. (ABBV) A Good Stock To Buy Now?

Is ABBV a good stock to buy? We came across a bullish thesis on AbbVie Inc. on X.com by @MoneyShow. In this article, we will summarize the bulls' thesis on ABBV. AbbVie Inc.'s share was trading at $225.42 as of June 9th. ABBV's trailing an... Full story